Outpatient Neutropenic Diet Study
Are Neutropenic Diets Beneficial to Improve Outcome?
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
This study is comparing two different diets. The cooked group will be allowed to eat only cooked food and cooked fruits or vegetables. The raw group will be able to eat cooked food and the addition of fresh fruits and vegetables. Patients will be monitored for infection in both groups. There are still certain foods that you are restricted from eating while receiving chemotherapy and you will be given a list of these restrictions.
Study Groups:
If you agree to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 groups.
Group 1: Raw group: You will be asked to eat at least 1 raw fruit or vegetable every day you are on study.
Group 2: Cooked group: You will eat only cooked foods while on study. The study doctor will give you a list of the foods that you are allowed to eat.
Your medical chart will be monitored while you are on study to check how often you need antibiotics to treat fever. or if you have an infection.
Diet Questionnaire:
You will be asked to fill out a diet questionnaire every week. The questionnaire will have 5 questions about the foods you have been eating. If you have been released from the hospital, you can return the questionnaire during your scheduled hospital visits,which typically take place 3 times per week. You will have no additional visits during this study. The questionnaire should take about 1-2 minutes each time.
Length of Study:
You will be taken off study if your white blood cell count returns to normal. If your white blood cell counts do not return to normal, the maximum time that you may be on study is 6 weeks.
This is an investigational study. There has not been enough research to prove if raw fruits and vegetables can increase your risk of infection. Many hospitals allow neutropenic patients to eat raw fruits and vegetables and other hospitals restrict fresh fruits and vegetables but, this has not been adequately investigated.
Up to 128 patients will take part in this study. All will be enrolled at M. D. Anderson.
Тип исследования
Регистрация (Действительный)
Фаза
- Фаза 2
Контакты и местонахождение
Места учебы
-
-
Texas
-
Houston, Texas, Соединенные Штаты, 77030
- U.T. M.D. Anderson Cancer Center
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Newly diagnosed patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia ( ALL), or myelodysplastic syndrome (MDS) receiving induction chemotherapy or AML, ALL or MDS patients who are in remission receiving consolidation chemotherapy.
- Patients who will be receiving myelosuppressive chemotherapy for their disease.
- Patients who will be able to stay in the Houston area for at least 4 weeks.
- Patients who can speak either English or Spanish.
Exclusion Criteria:
- Patients who present with an active infection such as pneumonia, bacteremia, urine, c. difficile or cellulitis infection.
- Patients who are unable to understand the diet questionnaire which will be written in either English or Spanish.
- Patients who are admitted to the protective environment.
- Patients who are younger than age 18 will not be entered in the study.
- Pregnant patients.
Учебный план
Как устроено исследование?
Детали дизайна
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Другой: "Raw" Group
Participants will eat cooked food and the addition of raw fruits and vegetables.
|
Diet containing fresh fruits and vegetables in addition to cooked food.
|
|
Другой: "Cooked" Group
Participants will eat only cooked foods.
|
Diet containing only cooked foods.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of Bactermia in Each Participant Group
Временное ограничение: 6 weeks
|
Participants evaluated for presence of bacteremia (gram positive, gram negative, and or candidemia).
Participants also evaluated for neutropenic fever requiring administration of antibiotics even if the participant does not have a positive blood culture on a weekly basis.
At least 2 positive blood cultures are needed for coagulase-negative staphylococci (CoNS) to be considered bacteremia.
|
6 weeks
|
|
Infection Rate
Временное ограничение: 6 weeks
|
Episodes of neutropenic fevers requiring IV antibiotics and or hospitalization because many times patients have an infection but there is no positive blood cultures.
Evaluation of bacteremia will be done by the two nurse investigators via a data questionnaire weekly, see Appendix E. Patients will require at least 2 positive blood cultures for coag neg staph to be considered bacteremia and if there are any other questionable organisms that could be a contaminant, an infectious disease expert is one of the co-investigators and this person will be consulted if this positive blood culture is considered an infection.
If the patient has a fever requiring antibiotics with this positive blood culture, then this will also be considered as to whether this is a true infection.
|
6 weeks
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Alison E Gardner, PhD, M.D. Anderson Cancer Center
Публикации и полезные ссылки
Полезные ссылки
Даты записи исследования
Изучение основных дат
Начало исследования
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оценивать)
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 2008-0369
- NCI-2009-01509 (Идентификатор реестра: NCI CTRP)
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .